{"patient_id": 43135, "patient_uid": "3728508-2", "PMID": 23956893, "file_path": "comm/PMC003xxxxxx/PMC3728508.xml", "title": "Early Complete Molecular Response to First-Line Nilotinib in Two Patients with Chronic Myeloid Leukemia Carrying the p230 Transcript", "patient": "The second patient, a 41-year-old woman, was diagnosed with chronic phase CML in November 2010. Her blood examination showed the following hematological parameters: Hb 12.5 g/dL, WBC 60 \u00d7 109/L, and platelets 1796 \u00d7 109/L. The classic Ph karyotype was confirmed in all the metaphases. RT-PCR detected the presence of the e19a2 transcript. After starting frontline treatment with nilotinib 600 mg per day, the patient achieved CCyR and CMR in 6 and 8 months, respectively. Currently, after 30 months, she is well and in CMR.", "age": "[[41.0, 'year']]", "gender": "F", "relevant_articles": "{'20447687': 1, '23380384': 1, '22937329': 2, '17021137': 1, '2224129': 1, '8839830': 1, '12100156': 1, '24551597': 1, '12476311': 1, '21641037': 1, '17656262': 1, '23956893': 2}", "similar_patients": "{'3728508-1': 2, '3420773-1': 1}"}